Literature DB >> 3581704

Anticardiolipin antibodies in a case of neuro-Behçet with superior vena caval occlusion.

C Salvarani, G Massai, P Macchioni, M Monti, F Rossi, R Baricchi.   

Abstract

The patient, a 55-year-old man with neuro-Behçet, developed superior vena caval occlusion. Antibodies to cardiolipin were detected in high titres in his serum and a decreased fibrinolysis was also found. It is suggested that anticardiolipin antibodies, perhaps decreasing fibrinolysis, may play an important pathogenic role in some patients with Behçet's disease.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3581704     DOI: 10.1007/bf02201008

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  13 in total

1.  Behçet's disease with decreased fibrinolysis and superior vena caval occlusion.

Authors:  T Chajek; M Fainaru
Journal:  Br Med J       Date:  1973-03-31

2.  Antiphospholipid antibodies in acute Guillain-Barré syndrome.

Authors:  E N Harris; H Englert; G Derve; G R Hughes; A Gharavi
Journal:  Lancet       Date:  1983-12-10       Impact factor: 79.321

3.  Arterial thrombosis, intrauterine death and "lupus" antiocoagulant: detection of immunoglobulin interfering with prostacyclin formation.

Authors:  L O Carreras; G Defreyn; S J Machin; J Vermylen; R Deman; B Spitz; A Van Assche
Journal:  Lancet       Date:  1981-01-31       Impact factor: 79.321

4.  Thrombosis, abortion, cerebral disease, and the lupus anticoagulant.

Authors:  G R Hughes
Journal:  Br Med J (Clin Res Ed)       Date:  1983-10-15

5.  Anticardiolipin antibodies: occurrence in Behçet's syndrome.

Authors:  R G Hull; E N Harris; A E Gharavi; A Tincani; R A Asherson; G Valesini; A M Denman; G Froude; G R Hughes
Journal:  Ann Rheum Dis       Date:  1984-10       Impact factor: 19.103

6.  Summary of the Third International Conference on Behçet's Disease, Tokyo, Japan, October 23-24, 1981.

Authors:  J D O'Duffy; T Lehner; C G Barnes
Journal:  J Rheumatol       Date:  1983-02       Impact factor: 4.666

7.  Antineuronal antibodies in systemic lupus erythematosus.

Authors:  H G Bluestein; V L Woods
Journal:  Arthritis Rheum       Date:  1982-07

8.  Neurologic involvement in seven patients with Behçet's disease.

Authors:  J D O'Duffy; N P Goldstein
Journal:  Am J Med       Date:  1976-08       Impact factor: 4.965

9.  Predisposing factors to thrombosis in systemic lupus erythematosus: possible relation to endothelial cell damage.

Authors:  E Angles-Cano; Y Sultan; J P Clauvel
Journal:  J Lab Clin Med       Date:  1979-08

10.  Cerebral infarction in systemic lupus: association with anticardiolipin antibodies.

Authors:  E N Harris; A E Gharavi; R A Asherson; M L Boey; G R Hughes
Journal:  Clin Exp Rheumatol       Date:  1984 Jan-Mar       Impact factor: 4.473

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.